Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region
Creators
- 1. Nuclear Medicine Department, University Hospital of Nantes (France)
- 2. CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes (France)
- 3. Nuclear Medicine Department, Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain (France)
- 4. Radiology, Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain (France)
- 5. Radiology, University Hospital of Nantes (France)
Description
To assess the rate and pattern of incidental interstitial lung abnormalities suggestive of COVID-19 on 18F-FDG PET/CT in asymptomatic cancer patients during the period of active COVID-19 circulation between March and April 2020 in a geographic area of low prevalence of the virus. 1396 18F-FDG PET/CT performed between January 1, 2020, and February 21, 2020, and between March 16, 2020, and April 17, 2020 for routine oncological indication were retrospectively analyzed. No patients had symptoms suggestive of COVID-19 at the time of the 18F-FDG PET/CT. Incidental interstitial pneumonias suggestive of COVID-19 were identified, and the 18F-FDG PET/CT patterns were described. We compared the incidence of these lesions in the pre-COVID and pandemic phases. We observed a 1.6% increase in interstitial lung abnormalities during the period of COVID-19 circulation. All had < 50% lung involvement. We describe a case series with typical and atypical interstitial pneumonias suggestive of COVID-19 as unilateral or bilateral with ground-glass opacity, consolidation, or crazy-paving patterns. The relatively low increase in incidental findings suggestive of COVID-19 infection on 18F-FDG PET/CT in asymptomatic cancer patients was in accordance with the low COVID-19 transmission in our geographic region. Nevertheless, nuclear medicine physicians should familiarize themselves with typical and atypical 18F-FDG PET/CT patterns suggestive of COVID-19 pneumonia and initiate appropriate intervention where necessary.
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-020-05014-3Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 48
- Journal Issue
- 1
- Journal Page Range
- p. 287-292
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 52022517
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; COMPARATIVE EVALUATIONS; CORONAVIRUSES; DIAGNOSIS; FLUORINE 18; FLUORODEOXYGLUCOSE; LUNGS; OPACITY; PNEUMONIA; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SYMPTOMS; UPTAKE
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EVALUATION; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; INFECTIOUS DISEASES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MICROORGANISMS; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; OPTICAL PROPERTIES; ORGANS; PARASITES; PHYSICAL PROPERTIES; RADIOACTIVE MATERIALS; RADIOISOTOPES; RESPIRATORY SYSTEM; RESPIRATORY SYSTEM DISEASES; TOMOGRAPHY; VIRAL DISEASES; VIRUSES